We are live on
!
Find out more
MIM
MetLife Investment Management Portfolio holdings
AUM
$19.6B
1-Year Est. Return
32.64%
This Fund
S&P 500
This Quarter
Est. Return
+0.51%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$11.2B
AUM Growth
-$244M
(-2.1%)
Cap. Flow
-$183M
Cap. Flow
% of AUM
-1.64%
Top 10 Holdings %
Top 10 Hldgs %
22.89%
Holding
2,613
New
177
Increased
266
Reduced
1,243
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$39.7M |
| 2 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$34.3M |
| 3 |
Moderna
MRNA
|
+$29.3M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$18.3M |
| 5 |
Match Group
MTCH
|
+$9.52M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Energy Transfer Partners
ET
|
+$35.7M |
| 2 |
Microsoft
MSFT
|
+$14.2M |
| 3 |
Apple
AAPL
|
+$13.2M |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$9.28M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$6.57M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.19% |
| 2 | Financials | 13.17% |
| 3 | Healthcare | 12.67% |
| 4 | Consumer Discretionary | 11.48% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2476
Pure Cycle
PCYO
$273M
| $90.9K | ﹤0.01% |
+6,829
| New | +$98.9K |
|
2477
ARS Pharmaceuticals
SPRY
$601M
| $90.8K | ﹤0.01% |
9,098
+3,571
| +65% | +$88.1K |
|
2478
Vera Bradley
VRA
$96.7M
| $90.8K | ﹤0.01% |
+9,645
| New | +$106K |
|
|
PVBC
2479
DELISTED
Provident Bancorp
PVBC
| $90.1K | ﹤0.01% |
+5,626
| New | +$90.7K |
|
2480
VirnetX Holding Corp
VHC
$65.8M
| $89.9K | ﹤0.01% |
+1,147
| New | +$93.8K |
|
2481
United States Lime & Minerals
USLM
$3.42B
| $89.8K | ﹤0.01% |
+3,715
| New | +$103K |
|
2482
Seres Therapeutics
MCRB
$47.4M
| $89.5K | ﹤0.01% |
643
-630
| -49% | -$123K |
|
2483
Rayonier Advanced Materials
RYAM
$561M
| $89.4K | ﹤0.01% |
11,915
-12,023
| -50% | -$82.7K |
|
2484
Torrid Holdings
CURV
$228M
| $88.8K | ﹤0.01% |
+5,758
| New | +$136K |
|
2485
iBio
IBIO
$73M
| $88.2K | ﹤0.01% |
+166
| New | +$103K |
|
2486
Beam Global
BEEM
$25.8M
| $87.6K | ﹤0.01% |
+3,199
| New | +$95.1K |
|
2487
Distribution Solutions Group
DSGR
$1.61B
| $87.2K | ﹤0.01% |
+3,488
| New | +$91.3K |
|
|
ASXC
2488
DELISTED
Asensus Surgical, Inc.
ASXC
| $87.2K | ﹤0.01% |
47,127
-42,111
| -47% | -$94.6K |
|
|
ITIC
2489
Investors Title Co
ITIC
$530M
| $86.9K | ﹤0.01% |
+476
| New | +$85.8K |
|
|
BRY
2490
DELISTED
Berry Corp
BRY
| $86.1K | ﹤0.01% |
11,939
-13,640
| -53% | -$80.6K |
|
2491
Geron
GERN
$1.01B
| $86K | ﹤0.01% |
62,775
-57,828
| -48% | -$77.2K |
|
|
ZYXI
2492
DELISTED
Zynex
ZYXI
| $85.7K | ﹤0.01% |
+8,281
| New | +$106K |
|
|
PSTL
2493
Postal Realty Trust
PSTL
$702M
| $84.2K | ﹤0.01% |
+4,518
| New | +$86.6K |
|
2494
Global Water Resources
GWRS
$219M
| $84K | ﹤0.01% |
+4,489
| New | +$83.2K |
|
|
LTRPA
2495
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $83.4K | ﹤0.01% |
+26,991
| New | +$100K |
|
2496
NewtekOne
NEWT
$370M
| $83.2K | ﹤0.01% |
3,000
| – | – |
|
2497
NWPX Infrastructure Inc
NWPX
$1.1B
| $82.9K | ﹤0.01% |
+3,497
| New | +$92.5K |
|
2498
Aldeyra Therapeutics
ALDX
$91.7M
| $82.7K | ﹤0.01% |
9,417
-9,627
| -51% | -$88.4K |
|
2499
Lindblad Expeditions
LIND
$2.24B
| $82.2K | ﹤0.01% |
5,634
-5,950
| -51% | -$83.6K |
|
|
NPTN
2500
DELISTED
NEOPHOTONICS CORP
NPTN
| $82K | ﹤0.01% |
9,412
-9,054
| -49% | -$82.5K |
|
Similar funds
SPIA
BG
PCM
CS
HHII
LF
EIM
MetLife Investment Management's Q3 2021 Portfolio in Review
As of Q3 2021, MetLife Investment Management held 2,613 positions worth $11.2B, down 2.1% from $11.4B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
MetLife Investment Management's Q3 2021 filing shows 177 new, 266 increased, 1,243 reduced and 46 closed positions. Its largest new stake was Moderna: 79,316 shares worth $30.5M. The largest sale was Energy Transfer Partners, an estimated $35.7M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- MetLife Investment Management's largest Q3 2021 buy was Moderna: 79,316 shares worth $30.5M.
- MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $39.7M increase.
- MetLife Investment Management's biggest Q3 2021 reduction was Energy Transfer Partners, cutting an estimated $35.7M.
- MetLife Investment Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $9.28M.
- MetLife Investment Management's ten largest holdings make up 23% of its $11.2B portfolio in Q3 2021.
- MetLife Investment Management opened 177 new positions and closed 46 in Q3 2021.
- MetLife Investment Management's portfolio value fell 2.1% quarter-over-quarter to $11.2B.
Based on MetLife Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.